WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Daniel Cornell
Associate
Corporate
London
daniel.cornell@wsgr.com
Download vCard
Open PDF

Daniel Cornell is an associate in the London office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s mergers and acquisitions and emerging companies practices, advising companies and investors in the technology and life sciences sectors from early stage to exit.

He has advised public and private companies on a broad range of corporate matters, including mergers and acquisitions, fundraisings, and corporate governance. He has also advised the UK government in connection with certain matters.

Prior to joining the firm, Daniel was an associate in the corporate and M&A department of Slaughter and May in London.

Experience

Daniel Cornell is an associate in the London office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s mergers and acquisitions and emerging companies practices, advising companies and investors in the technology and life sciences sectors from early stage to exit.

He has advised public and private companies on a broad range of corporate matters, including mergers and acquisitions, fundraisings, and corporate governance. He has also advised the UK government in connection with certain matters.

Prior to joining the firm, Daniel was an associate in the corporate and M&A department of Slaughter and May in London.

Education
  • Legal Practice Course (LPC), BPP University, London, United Kingdom
  • LL.B., Law, University of Nottingham
Admissions
  • Solicitor, England and Wales
Credentials
Education
  • Legal Practice Course (LPC), BPP University, London, United Kingdom
  • LL.B., Law, University of Nottingham
Admissions
  • Solicitor, England and Wales
Focus Areas
  • Corporate
  • Emerging Companies and Venture Capital
  • Mergers & Acquisitions
Recent Insights
Client Highlights
Firm Advises hyperexponential on Acquisition by Guidewire for up to $2.1 Billion
On October 27, 2026, Guidewire, a cloud platform for P&C insurers, announced that it entered into a definitive agreement to acquire hyperexponential, a London-based agentic platform provider of AI-native underwriting and pricing software for commercial lines P&C insurers, for a base purchase price of $1.7 billion in cash, subject to adjustments. The agreement also includes up to an additional $400 million in contingent consideration based on achievement of specified recurring revenue targets, bringing the total deal value to up to $2.1 billion and marking the transaction as the largest-ever M&A exit of a privately held, venture-backed UK technology company. hyperexponential is an existing Guidewire PartnerConnect Technology Alliance Partner and brings established trust and scale in underwriting, having powered underwriting decisions across more than $75 billion in annual commercial P&C premium for leading global insurers, reinsurers, and managing general agents. Wilson Sonsini Goodrich & Rosati advised hyperexponential on the transaction.
Learn More
Client Highlights
Firm Advises CoVet on Acquisition by IDEXX
On September 16, 2026, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The financial terms of the transaction were not disclosed. Wilson Sonsini Goodrich & Rosati advised CoVet on the transaction.

CoVet helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians’ time. The acquisition expands the value of IDEXX’s software, diagnostics, and AI offerings by making information more accessible, actionable, and connected across the practice. CoVet will be integrated into the IDEXX software ecosystem, which will continue to support other ambient scribe solutions and third-party integrations. CoVet will also continue to integrate with non-IDEXX practice management systems.

The Wilson Sonsini team that advised CoVet on the transaction included:
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.